← All news
Markets
Tenax Therapeutics, Inc. (TENX) Discusses Phase III LEVEL Trial Results for Oral Levosimendan in HFpEF Patients Transcript
Covered by 1 outlet
All coverage · 2 articles
Seeking Alpha
·Aug 11, 09:31 UTC
Tenax Therapeutics, Inc. (TENX) Discusses Phase III LEVEL Trial Results for Oral Levosimendan in HFpEF Patients - Slideshow
Seeking Alpha
·Aug 10, 14:58 UTC